These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33718177)

  • 21. Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
    Qiu SQ; Waaijer SJH; Zwager MC; de Vries EGE; van der Vegt B; Schröder CP
    Cancer Treat Rev; 2018 Nov; 70():178-189. PubMed ID: 30227299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging role of glycosylation in the polarization of tumor-associated macrophages.
    Mantuano NR; Oliveira-Nunes MC; Alisson-Silva F; Dias WB; Todeschini AR
    Pharmacol Res; 2019 Aug; 146():104285. PubMed ID: 31132403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor microenvironment components: Allies of cancer progression.
    Ribeiro Franco PI; Rodrigues AP; de Menezes LB; Pacheco Miguel M
    Pathol Res Pract; 2020 Jan; 216(1):152729. PubMed ID: 31735322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
    Fujimoto H; Sangai T; Ishii G; Ikehara A; Nagashima T; Miyazaki M; Ochiai A
    Int J Cancer; 2009 Sep; 125(6):1276-84. PubMed ID: 19479998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing.
    Belgiovine C; Digifico E; Anfray C; Ummarino A; Torres Andón F
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33050070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.
    Asimakopoulos F; Hope C; Johnson MG; Pagenkopf A; Gromek K; Nagel B
    J Leukoc Biol; 2017 Aug; 102(2):265-275. PubMed ID: 28254840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-stroma crosstalk: targeting stroma in breast cancer.
    Criscitiello C; Esposito A; Curigliano G
    Curr Opin Oncol; 2014 Nov; 26(6):551-5. PubMed ID: 25279962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.
    Ören B; Urosevic J; Mertens C; Mora J; Guiu M; Gomis RR; Weigert A; Schmid T; Grein S; Brüne B; Jung M
    J Pathol; 2016 Jul; 239(3):274-85. PubMed ID: 27038000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of cell surface proteoglycans in cancer immunotherapy.
    Espinoza-Sánchez NA; Götte M
    Semin Cancer Biol; 2020 May; 62():48-67. PubMed ID: 31336150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy.
    Henke E; Nandigama R; Ergün S
    Front Mol Biosci; 2019; 6():160. PubMed ID: 32118030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance.
    Krisnawan VE; Stanley JA; Schwarz JK; DeNardo DG
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050580
    [No Abstract]   [Full Text] [Related]  

  • 35. An Epic Advancement in Targeting Macrophages for Cancer Therapy Approach.
    Xiaohong L; Qiuxia F; Ruie L; Daijie W; Muluh TA; Zhang Y
    Curr Drug Deliv; 2024 Apr; ():. PubMed ID: 38591208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Tumor Microenvironment as a Driving Force of Breast Cancer Stem Cell Plasticity.
    Fico F; Santamaria-Martínez A
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33371274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker.
    Liot S; Aubert A; Hervieu V; Kholti NE; Schalkwijk J; Verrier B; Valcourt U; Lambert E
    Matrix Biol Plus; 2020 May; 6-7():100021. PubMed ID: 33543019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer.
    Steven A; Seliger B
    Breast Care (Basel); 2018 Mar; 13(1):16-21. PubMed ID: 29950962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment.
    Moraes LA; Kar S; Foo SL; Gu T; Toh YQ; Ampomah PB; Sachaphibulkij K; Yap G; Zharkova O; Lukman HM; Fairhurst AM; Kumar AP; Lim LHK
    Sci Rep; 2017 Dec; 7(1):17925. PubMed ID: 29263330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response.
    Lorenzo-Sanz L; Muñoz P
    Cancer Microenviron; 2019 Dec; 12(2-3):119-132. PubMed ID: 31583529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.